Titled “Emotion Dysregulation and Sleep-Time Masticatory Muscle Activity in Sleep Bruxism,” the study will span 150 subjects with data collection over a 21-day period during sleep.
Data collected during this period will include emotion reactivity and regulation, subjective sleep perception, sleep-time rhythmic masticatory muscle activity, and actigraphy.
The ECG monitors will provide an uninterrupted continuous stream of data that can be analyzed in real time or retrospectively for trends and patterns or to derive correlations between physiological and emotional impact.
Data from the ECG monitor will include heart rate and RR-intervals that can be used to derive heart-rate variability and physiological stress.
Unlike wire-based monitoring devices that can actually hinder sleep quality, the VivaLNK devices are extremely small, lightweight, and comfortable while sleeping, the company said.
“Since launching our vitals data platform, we’ve seen a myriad of medical and healthcare applications that are enabled by our solution,” said Jiang Li, CEO and VivaLNK.
“Now we can add sleep bruxism to the list of conditions including stress, depression, coronary artery disease, arrhythmia, neutropenia, and hypertension, which can all be monitored with our platform,” Li said.
The study is funded by the National Institute of Dental and Craniofacial Research.